Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of ferroquine in combination with artesunate for uncomplicated Plasmodium falciparum malaria in African adults and children was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Ferroquine (ferroquine)

Snippet

Sponsor: Sanofi | Conditions: Plasmodium Falciparum Infection | Phase 2 | Status: TERMINATED